Camilla Schalin-Jäntti

E-postadresscamilla.schalin-janttihelsinkifi

Forskningsoutput per år

Om du gjort några ändringar i Pure kommer de visas här snart.

Vetenskapsgrenar

3121 Allmänmedicin, inre medicin och annan klinisk medicin

95 Artikel
13 Översiktsartikel
9 Kapitel
1 Ledare

Novel PRUNE2 Germline Mutations in Aggressive and Benign Parathyroid Neoplasms
Storvall, S., Ryhanen, E., Karhu, A. & Schalin-Jantti, C., mars 2023, I: Cancers. 15, 5, 12 s.
Forskningsoutput: Tidskriftsbidrag › Artikel › Vetenskaplig › Peer review

Öppen tillgång
Adrenal androgens versus cortisol for primary aldosteronism subtype determination in adrenal venous sampling
Viukari, M., Kokko, E., Pörsti, I., Leijon, H., Vesterinen, T., Hinkka, T., Soinio, M., Schalin-Jäntti, C., Matikainen, N. & Nevalainen, P., sep. 2022, I: Clinical Endocrinology. 97, 3, s. 241-249 9 s.
Forskningsoutput: Tidskriftsbidrag › Artikel › Vetenskaplig › Peer review

Öppen tillgång
Fil
Arterial function, biomarkers, carcinoid syndrome and carcinoid heart disease in patients with small intestinal neuroendocrine tumours
Kostiainen, I., Karppinen, N., Simonen, P., Rosengård-Bärlund, M., Linden, R., Tarkkanen, M., Gordin, D., Rapola, J., Schalin-Jäntti, C. & Matikainen, N., juni 2022, I: Endocrine. 77, 1, s. 177-187 11 s.
Forskningsoutput: Tidskriftsbidrag › Artikel › Vetenskaplig › Peer review

Öppen tillgång
Fil
Changing Immunochemistry Platforms: Thyroid Function Test Comparison and Reference Intervals Based on Clinical Needs
Pelanti, J., Lamberg, T., Salopuro, T., Pussinen, C., Suvisaari, J., Joutsi-Korhonen, L., Schalin-Jäntti, C., Itkonen, O. & Anttonen, M., 29 okt. 2022, I: The journal of applied laboratory medicine. 7, 6, s. 1438-1444 7 s.
Forskningsoutput: Tidskriftsbidrag › Artikel › Vetenskaplig › Peer review

Öppen tillgång
Fil
Correlation of somatostatin receptor 1–5 expression, [⁶⁸ga]ga-dotanoc, [¹⁸f]f-fdg pet/ct and clinical outcome in a prospective cohort of pancreatic neuroendocrine neoplasms
Majala, S., Vesterinen, T., Seppänen, H., Mustonen, H., Sundström, J., Schalin-Jäntti, C., Gullichsen, R., Schildt, J., Kemppainen, J., Arola, J. & Kauhanen, S., 1 jan. 2022, I: Cancers. 14, 1, 15 s., 162.
Forskningsoutput: Tidskriftsbidrag › Artikel › Vetenskaplig › Peer review

Öppen tillgång
Fil

Camilla Schalin-Jäntti

Personlig profil

Vetenskapsgrenar

Internationellt och inhemskt samarbete

Fördjupning

Novel PRUNE2 Germline Mutations in Aggressive and Benign Parathyroid Neoplasms

Adrenal androgens versus cortisol for primary aldosteronism subtype determination in adrenal venous sampling

Arterial function, biomarkers, carcinoid syndrome and carcinoid heart disease in patients with small intestinal neuroendocrine tumours

Changing Immunochemistry Platforms: Thyroid Function Test Comparison and Reference Intervals Based on Clinical Needs

Correlation of somatostatin receptor 1–5 expression, [⁶⁸ga]ga-dotanoc, [¹⁸f]f-fdg pet/ct and clinical outcome in a prospective cohort of pancreatic neuroendocrine neoplasms

Camilla Schalin-Jäntti

Personlig profil

Vetenskapsgrenar

Internationellt och inhemskt samarbete

Publikationer

Novel PRUNE2 Germline Mutations in Aggressive and Benign Parathyroid Neoplasms

Adrenal androgens versus cortisol for primary aldosteronism subtype determination in adrenal venous sampling

Arterial function, biomarkers, carcinoid syndrome and carcinoid heart disease in patients with small intestinal neuroendocrine tumours

Changing Immunochemistry Platforms: Thyroid Function Test Comparison and Reference Intervals Based on Clinical Needs

Correlation of somatostatin receptor 1–5 expression, [68ga]ga-dotanoc, [18f]f-fdg pet/ct and clinical outcome in a prospective cohort of pancreatic neuroendocrine neoplasms

Correlation of somatostatin receptor 1–5 expression, [⁶⁸ga]ga-dotanoc, [¹⁸f]f-fdg pet/ct and clinical outcome in a prospective cohort of pancreatic neuroendocrine neoplasms